Skip to main content
SpringerLink
Log in

Bei kastrationsrefraktärem Prostatakarzinom ist die Chemotherapie die zentrale Option

  • Prisma
  • Pharmaforum
  • Published:
Uro-News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • 4. Expertise Prostata; Eltville, 14. August 2013 ; Veranstalter: Sanofi Aventis, Frankfurt am Main

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Ute Ayazpoor

Authors
  1. Ute Ayazpoor
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayazpoor, U. Bei kastrationsrefraktärem Prostatakarzinom ist die Chemotherapie die zentrale Option. Uro-News 17, 81 (2013). https://doi.org/10.1007/s00092-013-0386-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00092-013-0386-7

Search

Navigation